Compare topics

52,332
articles
1,474,722
citations
327
h-index
1901–2026
publication years

Most cited articles

#ArticleYearCitations
1Microenvironmental Regulation of Tumor Progression and Metastasis20137,351
2Quantitative Analysis of Dose-Effect Relationships: The Combined Effects of Multiple Drugs or Enzyme Inhibitors19847,097
3Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies20064,953
4The Biology and Management of Non-Small Cell Lung Cancer20184,386
5Inflammageing: Chronic Inflammation in Ageing, Cardiovascular Disease, and Frailty20183,444
6Quantitative Assessment of Antimalarial Activity in Vitro by a Semiautomated Microdilution Technique.19792,445
7A Comprehensive Map of Molecular Drug Targets20172,214
8Unresponsiveness of Colon Cancer to BRAF(V600E) Inhibition Through Feedback Activation of EGFR20121,958
9EZH2 Inhibition as a Therapeutic Strategy for Lymphoma With EZH2-Activating Mutations20121,736
10Endometriosis: Pathogenesis and Treatment20141,703
11The Epidemiology of Urinary Tract Infection20101,447
12Local Clearance of Senescent Cells Attenuates the Development of Post-Traumatic Osteoarthritis and Creates a Pro-Regenerative Environment20171,446
13A Bayesian Neural Network Method for Adverse Drug Reaction Signal Generation19981,410
14Induced Pluripotent Stem Cell Technology: A Decade of Progress20171,402
15Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin20011,379
16Metformin Improves Healthspan and Lifespan in Mice20131,355
17Recommendations for Presenting Analyses of Effect Modification and Interaction.20121,327
18The Role of Synovitis in Pathophysiology and Clinical Symptoms of Osteoarthritis20101,309
19Spectral Studies of Drug Interaction With Hepatic Microsomal Cytochrome19671,303
20Epithelial Cell Cycle Arrest in G2/M Mediates Kidney Fibrosis After Injury20101,275
21GLP-1 Receptor Agonists for Individualized Treatment of Type 2 Diabetes Mellitus20121,273
22Continued Improvement in Survival in Multiple Myeloma: Changes in Early Mortality and Outcomes in Older Patients20141,265
23Mechanisms of Action of Hydroxychloroquine and Chloroquine: Implications for Rheumatology20201,235
24Metformin—Mode of Action and Clinical Implications for Diabetes and Cancer20141,233
25A Phase 1 Evaluation of the Pharmacokinetic/Pharmacodynamic Interaction of the Anti-Malarial Agents KAF156 and Piperaquine20181,168
26Spiroindolones, a Potent Compound Class for the Treatment of Malaria20101,156
27Clinical Response to Aminoglycoside Therapy: Importance of the Ratio of Peak Concentration to Minimal Inhibitory Concentration.19871,135
28A Tutorial on Interaction20141,092
29Mapping Human Microbiome Drug Metabolism by Gut Bacteria and Their Genes20191,090
30Herb-Drug Interactions20001,089
31Towards the Sustainable Discovery and Development of New Antibiotics20211,069
32Tau-Targeting Therapies for Alzheimer Disease20181,029
33Artesunate Versus Quinine for Treatment of Severe Falciparum Malaria: A Randomised Trial20051,028
34Analysis of Drug Combinations: Current Methodological Landscape20151,017
35Systematic Overview of Warfarin and Its Drug and Food Interactions20051,004
36Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both2017988
37Platelet Biology and Functions: New Concepts and Clinical Perspectives2019977
38ZNRF3 Promotes Wnt Receptor Turnover in an R-Spondin-Sensitive Manner2012940
39Artemisinins Target the SERCA of Plasmodium falciparum2003936
40Drug-Drug Interactions for UDP-Glucuronosyltransferase Substrates: A Pharmacokinetic Explanation for Typically Observed Low Exposure (AUCi/AUC) Ratios.2004932
41Artesunate Versus Quinine in the Treatment of Severe Falciparum Malaria in African Children (AQUAMAT): An Open-Label, Randomised Trial2010921
42Adverse Events and Complications Associated With Intravitreal Injection of Anti-VEGF Agents: A Review of Literature2013920
43Quinine, an Old Anti-Malarial Drug in a Modern World: Role in the Treatment of Malaria2011902
44Mechanisms of Drug Combinations: Interaction and Network Perspectives2009901
45Integration of the Drug–Gene Interaction Database (DGIdb 4.0) With Open Crowdsource Efforts2021885
46The SGLT2 Inhibitor Empagliflozin in Patients Hospitalized for Acute Heart Failure: A Multinational Randomized Trial2022885
47A Method for Assessing Drug Therapy Appropriateness1992878
48Predicting in Vivo Drug Interactions From in Vitro Drug Discovery Data2005870
49Use of Prescription and Over-the-Counter Medications and Dietary Supplements Among Older Adults in the United States2008870
50The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis2011864
51Two-Year Effects of Semaglutide in Adults With Overweight or Obesity: The STEP 5 Trial2022864
52Qinghaosu (Artemisinin): The Price of Success2008854
53The Role of Intestinal P-Glycoprotein in the Interaction of Digoxin and Rifampin1999854
54Anti-Diabetic Drugs Inhibit Obesity-Linked Phosphorylation of PPARγ by Cdk52010851
55Interaction of Drugs With Bovine and Human Serum Albumin2002850
56Metal Chelation and Inhibition of Bacterial Growth in Tissue Abscesses2008831
57Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin: Anatomy OF DRUG SITE I2001815
58Cytochrome P4502C9: An Enzyme of Major Importance in Human Drug Metabolism1998808
59Assessment and Management of Blood-Pressure Variability2013808
60Data-Driven Prediction of Drug Effects and Interactions2012800
61Improving Drug-Therapy Decisions Through Educational Outreach1983799
62The Conduct of in Vitro and in Vivo Drug-Drug Interaction Studies: A Pharmaceutical Research and Manufacturers of America (PhRMA) Perspective.2003792
63The Anticholinergic Risk Scale and Anticholinergic Adverse Effects in Older Persons2008792
64Uncovering the Essential Genes of the Human Malaria Parasite Plasmodium falciparum by Saturation Mutagenesis2018776
65Host-Directed Therapies for Bacterial and Viral Infections2018775
66Mitochondrial Function as a Therapeutic Target in Heart Failure2017773
67Dysfunctional HDL and Atherosclerotic Cardiovascular Disease2016763
68Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model2015758
69SGLT2 Inhibitors: Mechanisms of Cardiovascular Benefit Beyond Glycaemic Control2020756
70SynergyFinder 3.0: An Interactive Analysis and Consensus Interpretation of Multi-Drug Synergies Across Multiple Samples2022745
71Flucytosine: A Review of Its Pharmacology, Clinical Indications, Pharmacokinetics, Toxicity and Drug Interactions2000743
72Nitric Oxide Signalling in Cardiovascular Health and Disease2018736
73PPARs in Obesity-Induced T2DM, Dyslipidaemia and NAFLD2017730
74Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference2012729
75Medical Need, Scientific Opportunity and the Drive for Antimalarial Drugs2002724
76Abdominal Aortic Aneurysm: Update on Pathogenesis and Medical Treatments2019724
77Clinical Pharmacokinetics of Tacrolimus1995721
78Herbal Medicinals: Selected Clinical Considerations Focusing on Known or Potential Drug-Herb Interactions1998719
79DGIdb 3.0: A Redesign and Expansion of the Drug–Gene Interaction Database2018713
80Quinolines and Structurally Related Heterocycles as Antimalarials2010707
81The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer2005698
82Pharmacokinetic Interactions With Rifampicin2003697
83The Rising Tide of Polypharmacy and Drug-Drug Interactions: Population Database Analysis 1995–20102015697
84The NLRP3 Inflammasome in Acute Myocardial Infarction2018693
85Grapefruit Juice–Drug Interactions1998688
86Drug Interactions at the GABA Receptor-Ionophore Complex.1982686
87Expression of PD-L1, PD-L2, PD-1 and CTLA4 in Myelodysplastic Syndromes Is Enhanced by Treatment With Hypomethylating Agents2014683
88Diuretic Therapy1998677
89A Drug Burden Index to Define the Functional Burden of Medications in Older People2007676
90N-Acetylcysteine—A Safe Antidote for Cysteine/Glutathione Deficiency2007676
91Bile Acid Receptors as Targets for Drug Development2014675
92Pharmacokinetics and Dosage Adjustment in Patients With Hepatic Dysfunction2008669
93Arterial Thrombosis—Insidious, Unpredictable and Deadly2011668
94A Phase 3 Study of Deferasirox (ICL670), a Once-Daily Oral Iron Chelator, in Patients With β-Thalassemia2006666
95Artemisinin: Mechanisms of Action, Resistance and Toxicity2002654
96Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation2003653
97Methotrexate and Its Mechanisms of Action in Inflammatory Arthritis2020652
98Cancer Immunotherapy — Immune Checkpoint Blockade and Associated Endocrinopathies2017647
99Defective N-Oxidation of Sparteine in Man: A New Pharmacogenetic Defect1979638
100Analysis of Combined Drug Effects: A New Look at a Very Old Problem1983636